Scarica l'app Stockscreener
14.01
4.63%
-0.68
Dopo l'orario di chiusura:
14.01
Precedente Chiudi:
$14.69
Aprire:
$14.36
Volume 24 ore:
106.27K
Relative Volume:
1.51
Capitalizzazione di mercato:
$198.61M
Reddito:
$166.88M
Utile/perdita netta:
$-74.18M
Rapporto P/E:
-2.7633
EPS:
-5.07
Flusso di cassa netto:
$1.14M
1 W Prestazione:
-7.28%
1M Prestazione:
-16.90%
6M Prestazione:
-43.94%
1 anno Prestazione:
-46.14%
Intervallo 1D:
$13.71
$15.40
Intervallo di 1 settimana:
$13.71
$15.45
Portata 52W:
$13.71
$29.11
Anika Therapeutics Inc Stock (ANIK) Company Profile
Nome
Anika Therapeutics Inc
Settore
Telefono
(781) 457-9000
Indirizzo
32 WIGGINS AVENUE, BEDFORD, MA
Confronta ANIK con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ANIK
Anika Therapeutics Inc
|
14.01 | 198.61M | 166.88M | -74.18M | 1.14M | -5.07 |
|
ZTS
Zoetis Inc
|
151.73 | 67.94B | 9.26B | 2.49B | 2.30B | 5.47 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.72 | 46.50B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
HLN
Haleon Plc Adr
|
9.89 | 44.66B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
13.80 | 15.81B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
292.46 | 13.14B | 2.76B | 1.11B | 898.10M | 22.77 |
Anika Therapeutics Inc Stock (ANIK) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-11-01 | Reiterato | Barrington Research | Outperform |
| 2023-08-14 | Aggiornamento | Barrington Research | Mkt Perform → Outperform |
| 2023-03-07 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| 2022-11-09 | Aggiornamento | Barrington Research | Mkt Perform → Outperform |
| 2022-10-14 | Ripresa | Stephens | Equal-Weight |
| 2022-03-09 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| 2022-03-09 | Downgrade | Stephens | Overweight → Equal-Weight |
| 2021-11-16 | Iniziato | Stephens | Overweight |
| 2021-07-16 | Iniziato | UBS | Neutral |
| 2020-12-16 | Aggiornamento | Barrington Research | Mkt Perform → Outperform |
| 2020-05-08 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| 2020-01-21 | Aggiornamento | Sidoti | Neutral → Buy |
| 2020-01-10 | Aggiornamento | First Analysis Sec | Outperform → Strong Buy |
| 2019-11-05 | Iniziato | BWS Financial | Sell |
| 2019-09-24 | Reiterato | Barrington Research | Outperform |
| 2019-09-23 | Downgrade | First Analysis Sec | Strong Buy → Outperform |
| 2019-07-25 | Aggiornamento | First Analysis Sec | Neutral → Strong Buy |
| 2019-02-22 | Downgrade | First Analysis Sec | Outperform → Neutral |
| 2019-02-22 | Downgrade | Sidoti | Buy → Neutral |
| 2018-07-27 | Aggiornamento | Barrington Research | Mkt Perform → Outperform |
| 2018-06-20 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| 2018-06-20 | Downgrade | First Analysis Sec | Overweight → Equal-Weight |
| 2018-05-04 | Aggiornamento | Barrington Research | Mkt Perform → Outperform |
| 2018-02-23 | Downgrade | Barrington Research | Outperform → Mkt Perform |
| 2018-01-24 | Aggiornamento | First Analysis Sec | Equal-Weight → Overweight |
| 2017-10-27 | Reiterato | Barrington Research | Outperform |
| 2016-05-09 | Aggiornamento | Singular Research | BUY - Long-Term → Buy |
| 2016-04-27 | Downgrade | Northland Capital | Outperform → Market Perform |
| 2016-02-26 | Reiterato | Barrington Research | Outperform |
Mostra tutto
Anika Therapeutics Inc Borsa (ANIK) Ultime notizie
Anika Therapeutics, Inc. (NASDAQ:ANIK) Position Trimmed by HighTower Advisors LLC - Defense World
Are Options Traders Betting on a Big Move in Anika Therapeutics (ANIK) Stock? - TradingView
Viscosupplementation Market Is Booming Worldwide | Anika - openPR.com
Europe Viscosupplementation Market Projected To Witness - openPR.com
Anika Therapeutics stock hits 52-week low at $14.9 By Investing.com - Investing.com South Africa
Anika Therapeutics stock hits 52-week low at $14.9 - Investing.com India
How the (ANIK) price action is used to our Advantage - news.stocktradersdaily.com
Anika Therapeutics, Inc. (NASDAQ:ANIK) Stock Position Reduced by Charles Schwab Investment Management Inc. - Defense World
Hammertoe Solution Market Size, Trends 2031 By Key Players- - openPR.com
Anika Therapeutics, Inc. (NASDAQ:ANIK) Shares Acquired by Bank of New York Mellon Corp - Defense World
Europe Viscosupplementation Market Set to Witness Significant - openPR.com
Reviewing Anika Therapeutics (NASDAQ:ANIK) and InspireMD (NYSE:NSPR) - Defense World
Anika Therapeutics Faces Financial Strain Amid Geopolitical Tensions and Supply Chain Disruptions - TipRanks
Anika Therapeutics, Inc. SEC 10-K Report - TradingView
Viscosupplementation Market Is Booming Worldwide | Anika Therapeutics Inc., Seikagaku Corporation - openPR.com
Q1 Earnings Forecast for ANIK Issued By Barrington Research - Defense World
Anika Therapeutics, Inc. (NASDAQ:ANIK) Q4 2024 Earnings Call Transcript - MSN
Anika Therapeutics (NASDAQ:ANIK) Stock Rating Upgraded by StockNews.com - Defense World
Barrington Research Lowers Anika Therapeutics (NASDAQ:ANIK) Price Target to $20.00 - Defense World
Anika Therapeutics (NASDAQ:ANIK investor three-year losses grow to 45% as the stock sheds US$26m this past week - Simply Wall St
Anika Therapeutics Full Year 2024 Earnings: Misses Expectations - Yahoo Finance
Anika Therapeutics stock hits 52-week low at $15.34 By Investing.com - Investing.com Australia
Anika Therapeutics’ Earnings Call: Growth Amid Challenges - TipRanks
Anika Therapeutics stock hits 52-week low at $15.34 - Investing.com
Earnings call transcript: Anika Therapeutics Q4 2024 beats EPS forecast, stock dips - Investing.com Australia
Anika Therapeutics Inc (ANIK) Q4 2024 Earnings Call Highlights: Navigating Growth and Challenges - Yahoo Finance
Anika Therapeutics Reports Steady Growth and Strategic Focus - TipRanks
Earnings call transcript: Anika Therapeutics Q4 2024 beats EPS forecast, stock dips By Investing.com - Investing.com South Africa
Anika Therapeutics (ANIK) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance
Anika Therapeutics Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Anika: Q4 Earnings Snapshot -March 12, 2025 at 04:34 pm EDT - Marketscreener.com
ANIKA THERAPEUTICS Earnings Results: $ANIK Reports Quarterly Earnings - Nasdaq
Anika Therapeutics Q4 Swings to Adjusted Loss, Revenue Rises -- Shares Drop After Hours - Marketscreener.com
Anika Therapeutics, Inc. Reports 2024 Financial Results with 17% Growth in Commercial Channel Revenue and Key Strategic Advances - Nasdaq
Anika Reports Fourth Quarter and Full Year 2024 Financial Results - GlobeNewswire
Anika's Commercial Channel Soars 25% in Q4: Inside the Transformation Strategy - StockTitan
Anika Therapeutics Sells Parcus Medical to Medacta - TipRanks
Anika Therapeutics at CG 2025 Musculoskeletal Conference: Strategic Growth Unveiled - Investing.com Canada
Anika Therapeutics at CG 2025 Musculoskeletal Conference: Strategic Growth Unveiled By Investing.com - Investing.com South Africa
ANIKA THERAPEUTICS Earnings Preview: Recent $ANIK Insider Trading, Hedge Fund Activity, and More - Nasdaq
Anika Therapeutics Reports Third-Quarter Financial Results - AOL
(ANIK) Investment Report - news.stocktradersdaily.com
Anika Therapeutics falls after its completes divestiture of Parcus Medical business - TradingView
Anika Completes Divestiture of Parcus Medical - citybiz
Anika Therapeutics Completes Divestiture of Parcus Medical to Medacta -March 07, 2025 at 06:38 am EST - Marketscreener.com
Anika Therapeutics (ANIK) Projected to Post Quarterly Earnings on Wednesday - MarketBeat
Anika Therapeutics Completes Sale of Parcus Medical to Medacta Group SA - Nasdaq
Can Anika's Strategic Exit from Parcus Medical Transform Its Growth Trajectory? - StockTitan
Anika Therapeutics Inc Azioni (ANIK) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
5.86%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):